AG-946

Overview

AG-946 is an oral, novel Pyruvate Kinase (PK) Activator that is currently in development. It is being studied for use in several hemolytic anemic conditions such as PK deficiency, MDS associated anemia and sickle cell disease.

SparkCures ID 468
Generic Name AG-946
Treatment Classifications
  • Pyruvate Kinase (PKR)

Clinical Trials

Resources

There are no resources, links or videos to display for this treatment.